Literature DB >> 23288025

C-terminal FGF23 fragments: present but not seen?

E R Smith, L P McMahon, S G Holt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23288025     DOI： 10.1007/s00198-012-2235-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  5 in total

1.  Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

Authors:  Yuji Yamazaki; Ryo Okazaki; Minako Shibata; Yukihiro Hasegawa; Kohei Satoh; Toshihiro Tajima; Yasuhiro Takeuchi; Toshiro Fujita; Kazuhiko Nakahara; Takeyoshi Yamashita; Seiji Fukumoto
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

2.  Biological variability of plasma intact and C-terminal FGF23 measurements.

Authors:  Edward R Smith; Michael M Cai; Lawrence P McMahon; Stephen G Holt
Journal:  J Clin Endocrinol Metab       Date:  2012-06-11       Impact factor: 5.958

3.  Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies.

Authors:  Edward R Smith; Martin L Ford; Laurie A Tomlinson; Gary Weaving; Bernard F Rocks; Chakravarthi Rajkumar; Stephen G Holt
Journal:  Clin Chim Acta       Date:  2011-02-12       Impact factor: 3.786

4.  Serum FGF23 levels in normal and disordered phosphorus homeostasis.

Authors:  Thomas J Weber; Shiguang Liu; Olafur S Indridason; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2003-07       Impact factor: 6.741

5.  Intact fibroblast growth factor 23 and fragments in plasma from Gambian children.

Authors:  V Braithwaite; S F A Bruggraber; A Prentice
Journal:  Osteoporos Int       Date:  2012-05-31       Impact factor: 4.507
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.